Cell Therapy

News

AZ makes another cell therapy play with $1.2bn Gracell buy

AstraZeneca has lined up a $1.2 billion takeover deal for Chinese biotech Gracell Biotechnologies, bolting a series of cell therapies for cancer and autoimmune diseases on

Market Access

Why the Novo Nordisk Foundation is betting big on stem cells

One area where the Novo Nordisk Foundation has invested quite heavily is in cell therapy, especially stem cell research.

R&D

How birth tissue donations are fuelling the cell therapy rev...

As the burgeoning field of cell therapy evolves, so do the practices around obtaining the raw biological material needed to create these life-changing treatments.

News

Cellectis rockets on gene-editing alliance with AstraZeneca

Shares in Cellectis shot up this morning after the French biotech revealed a wide-ranging alliance with AstraZeneca, which includes $245 million in near-term financial com

News

Bayer backs cell therapy ambition with $250m US facility

Bayer is backing up its move into the cell therapy category led by subsidiary BlueRock Therapeutics with a $250 million investment in a new manufacturing facility in Berke

News

FDA advisors unconvinced by BrainStorm’s ALS cell therapy

An FDA advisory committee has voted by a huge margin that BrainStorm’s stem cell therapy for amyotrophic lateral sclerosis (ALS) – NurOwn – does not have enough data to su

AZ makes another cell therapy play with $1.2bn Gracell buy

Why the Novo Nordisk Foundation is betting big on stem cells

How birth tissue donations are fuelling the cell therapy rev...

Cellectis rockets on gene-editing alliance with AstraZeneca

Bayer backs cell therapy ambition with $250m US facility

FDA advisors unconvinced by BrainStorm’s ALS cell therapy

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Cell Therapy

Editor's Picks